| Year |
Citation |
Score |
| 2024 |
Nghiemphu PL, Vitte J, Dombi E, Nguyen T, Wagle N, Ishiyama A, Sepahdari AR, Cachia D, Widemann BC, Brackmann DE, Doherty JK, Kalamarides M, Giovannini M. Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma. Journal of Neuro-Oncology. PMID 38372904 DOI: 10.1007/s11060-024-04596-4 |
0.728 |
|
| 2023 |
Staedtke V, Anstett K, Bedwell D, Giovannini M, Keeling K, Kesterson R, Kim Y, Korf B, Leier A, McManus ML, Sarnoff H, Vitte J, Walker JA, Plotkin SR, Wallis D. Gene-targeted therapy for neurofibromatosis and schwannomatosis: The path to clinical trials. Clinical Trials (London, England). 17407745231207970. PMID 37937606 DOI: 10.1177/17407745231207970 |
0.736 |
|
| 2023 |
Jordan JT, Orr CC, Thalheimer RD, Cambillo JV, Beauchamp RL, Shaikh G, Muzikansky A, Stemmer-Rachamimov A, Giovannini M, Kalamarides M, Barker FG, Ramesh V, Plotkin SR. Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-Oncology Advances. 5: vdad041. PMID 37215956 DOI: 10.1093/noajnl/vdad041 |
0.31 |
|
| 2023 |
Chiasson-MacKenzie C, Vitte J, Liu CH, Wright EA, Flynn EA, Stott SL, Giovannini M, McClatchey AI. Cellular mechanisms of heterogeneity in NF2-mutant schwannoma. Nature Communications. 14: 1559. PMID 36944680 DOI: 10.1038/s41467-023-37226-0 |
0.784 |
|
| 2022 |
Prabhakar S, Beauchamp RL, Cheah PS, Yoshinaga A, Haidar EA, Lule S, Mani G, Maalouf K, Stemmer-Rachamimov A, Jung DH, Welling DB, Giovannini M, Plotkin SR, Maguire CA, Ramesh V, et al. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2. Molecular Therapy. Methods & Clinical Development. 26: 169-180. PMID 35846573 DOI: 10.1016/j.omtm.2022.06.012 |
0.431 |
|
| 2022 |
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 35674741 DOI: 10.1016/j.gim.2022.05.007 |
0.316 |
|
| 2020 |
Ma J, Klemm J, Gerardo-Ramírez M, Frappart L, Castven D, Becker D, Zoch A, Parent R, Bartosch B, Minnich K, Giovannini M, Danckwardt S, Hartmann N, Morrison H, Herrlich P, et al. CD44 (Cluster of differentiation 44) promotes osteosarcoma progression in mice lacking the tumor suppressor Merlin. International Journal of Cancer. PMID 32525563 DOI: 10.1002/Ijc.33144 |
0.339 |
|
| 2019 |
Ahmed SG, Ahmed A, Maguire CA, Doha M, Sagers J, Lewis RM, Muzikansky A, Giovannini M, Stemmer-Rachamimov A, Stankovic KM, Fulci G, Brenner GJ. Gene therapy with apoptosis-associated speck-like protein (ASC), a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo. Neuro-Oncology. PMID 30977509 DOI: 10.1093/Neuonc/Noz065 |
0.403 |
|
| 2019 |
Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. American Journal of Medical Genetics. Part A. PMID 30908866 DOI: 10.1002/Ajmg.A.61112 |
0.468 |
|
| 2019 |
Roberts DS, Maurya R, Takemon Y, Vitte J, Gong L, Zhao J, Wong CH, Slattery W, Peng KA, Lekovic G, Schwartz MS, Bulsara K, Ngan CY, Giovannini M, Wei CL. Linked-read Sequencing Analysis Reveals Tumor-specific Genome Variation Landscapes in Neurofibromatosis Type 2 (NF2) Patients. Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology. 40: e150-e159. PMID 30624408 DOI: 10.1097/Mao.0000000000002096 |
0.787 |
|
| 2019 |
Fuse MA, Dinh CT, Vitte J, Kirkpatrick J, Mindos T, Plati SK, Young JI, Huang J, Carlstedt A, Franco MC, Brnjos K, Nagamoto J, Petrilli A, Copik AJ, Soulakova JN, ... ... Giovannini M, et al. Preclinical Assessment of MEK1/2 Inhibitors for Neurofibromatosis Type 2-Associated Schwannomas Reveal Differences in Efficacy and Drug Resistance Development. Neuro-Oncology. PMID 30615146 DOI: 10.1093/Neuonc/Noz002 |
0.785 |
|
| 2019 |
Osum S, Stemmer-Rachamimov A, Widemann B, Dombi E, Vitte J, Dahiya S, Rizvi T, Ratner N, Messiaen L, Gutmann D, Giovannini M, Moertel C, Largaespada D, Watson A. TMOD-23. PRECLINICAL DRUG EVALUATION IN A GENETICALLY ENGINEERED MINIPIG MODEL OF NEUROFIBROMATOSIS TYPE 1 Neuro-Oncology. 21: vi267-vi267. DOI: 10.1093/Neuonc/Noz175.1122 |
0.776 |
|
| 2019 |
Vitte J, Gao F, Coppola G, Judkins AR, Giovannini M. TMOD-15. SPATIOTEMPORAL LOSS OF SMARCB1 IN EARLY NEURAL CREST LINEAGE LEADS TO DIFFERENT MOLECULAR SUBTYPES OF RHABDOID TUMORS Neuro-Oncology. 21: ii124-ii124. DOI: 10.1093/Neuonc/Noz036.252 |
0.754 |
|
| 2018 |
Isakson SH, Rizzardi AE, Coutts AW, Carlson DF, Kirstein MN, Fisher J, Vitte J, Williams KB, Pluhar GE, Dahiya S, Widemann BC, Dombi E, Rizvi T, Ratner N, Messiaen L, ... ... Giovannini M, et al. Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. Communications Biology. 1: 158. PMID 30302402 DOI: 10.1038/s42003-018-0163-y |
0.749 |
|
| 2018 |
Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, et al. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. 176: 1258-1269. PMID 29681099 DOI: 10.1002/Ajmg.A.38675 |
0.498 |
|
| 2018 |
Nghiemphu P, Everson R, Giovannini M, Reider-Demer M, Wainberg Z, Ishiyama A. CMET-04. METASTATIC GASTROINTESTINAL CANCER TO THE SKULL BASE MIMICKING NF2 Neuro-Oncology. 20: vi54-vi54. DOI: 10.1093/Neuonc/Noy148.217 |
0.371 |
|
| 2017 |
Paganini I, Capone GL, Vitte J, Sestini R, Putignano AL, Giovannini M, Papi L. Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma. Journal of Neuro-Oncology. PMID 29230670 DOI: 10.1007/S11060-017-2711-6 |
0.767 |
|
| 2017 |
Vitte J, Gao F, Coppola G, Judkins AR, Giovannini M. Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development. Nature Communications. 8: 300. PMID 28824165 DOI: 10.1038/S41467-017-00346-5 |
0.798 |
|
| 2017 |
Paldor I, Abbadi S, Bonne N, Ye X, Rodriguez FJ, Rowshanshad D, Itzoe M, Vigilar V, Giovannini M, Brem H, Blakeley JO, Tyler BM. The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma. Journal of Neuro-Oncology. PMID 28735458 DOI: 10.1007/S11060-017-2567-9 |
0.431 |
|
| 2017 |
Blakeley JO, Bakker A, Barker A, Clapp W, Ferner R, Fisher MJ, Giovannini M, Gutmann DH, Karajannis MA, Kissil JL, Legius E, Lloyd AC, Packer RJ, Ramesh V, Riccardi VM, et al. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. PMID 28436162 DOI: 10.1002/Ajmg.A.38239 |
0.479 |
|
| 2017 |
Goutagny S, Giovannini M, Kalamarides M. A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomas. Journal of Neuro-Oncology. 133: 443-445. PMID 28434114 DOI: 10.1007/S11060-017-2447-3 |
0.301 |
|
| 2016 |
Shi Y, Bollam SR, White SM, Laughlin SZ, Graham GT, Wadhwa M, Chen H, Nguyen C, Vitte J, Giovannini M, Toretsky J, Yi C. Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression. Developmental Cell. PMID 27818180 DOI: 10.1016/J.Devcel.2016.09.027 |
0.791 |
|
| 2016 |
Bonne NX, Vitte J, Chareyre F, Karapetyan G, Khankaldyyan V, Tanaka K, Moats RA, Giovannini M. An allograft mouse model for the study of hearing loss secondary to vestibular schwannoma growth. Journal of Neuro-Oncology. PMID 27177628 DOI: 10.1007/S11060-016-2150-9 |
0.751 |
|
| 2015 |
Peyre M, Salaud C, Clermont-Taranchon E, Niwa-Kawakita M, Goutagny S, Mawrin C, Giovannini M, Kalamarides M. PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss. Oncotarget. 6: 32713-22. PMID 26418719 DOI: 10.18632/Oncotarget.5296 |
0.398 |
|
| 2015 |
Zoch A, Mayerl S, Schulz A, Greither T, Frappart L, Rübsam J, Heuer H, Giovannini M, Morrison H. Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation. Plos One. 10: e0129151. PMID 26258444 DOI: 10.1371/Journal.Pone.0129151 |
0.403 |
|
| 2015 |
Goutagny S, Raymond E, Esposito-Farese M, Trunet S, Mawrin C, Bernardeschi D, Larroque B, Sterkers O, Giovannini M, Kalamarides M. Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas. Journal of Neuro-Oncology. 122: 313-20. PMID 25567352 DOI: 10.1007/S11060-014-1710-0 |
0.396 |
|
| 2015 |
Serinagaoglu Y, Paré J, Giovannini M, Cao X. Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development. Developmental Biology. 398: 97-109. PMID 25433207 DOI: 10.1016/J.Ydbio.2014.11.017 |
0.411 |
|
| 2015 |
Paganini I, Chang VY, Capone GL, Vitte J, Benelli M, Barbetti L, Sestini R, Trevisson E, Hulsebos TJ, Giovannini M, Nelson SF, Papi L. Expanding the mutational spectrum of LZTR1 in schwannomatosis. European Journal of Human Genetics : Ejhg. 23: 963-8. PMID 25335493 DOI: 10.1038/Ejhg.2014.220 |
0.785 |
|
| 2015 |
Vitte J, Chareyre F, Stemmer-Rachamimov A, Judkins A, Giovannini M. PM-02 * CONDITIONAL INACTIVATION OF SMARCB1 IN P0 PERMISSIVE MOUSE CELLS GENERATES RHABDOID TUMORS IN THE PERIPHERAL NERVOUS SYSTEM AND IN THE BRAIN Neuro-Oncology. 17: iii31-iii31. DOI: 10.1093/Neuonc/Nov061.125 |
0.783 |
|
| 2014 |
Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, et al. Update from the 2013 International Neurofibromatosis Conference. American Journal of Medical Genetics. Part A. 164: 2969-78. PMID 25255738 DOI: 10.1002/Ajmg.A.36754 |
0.492 |
|
| 2014 |
Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics. Part A. 164: 563-78. PMID 24443315 DOI: 10.1002/Ajmg.A.36312 |
0.504 |
|
| 2014 |
Giovannini M, Bonne NX, Vitte J, Chareyre F, Tanaka K, Adams R, Fisher LM, Valeyrie-Allanore L, Wolkenstein P, Goutagny S, Kalamarides M. mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro-Oncology. 16: 493-504. PMID 24414536 DOI: 10.1093/Neuonc/Not242 |
0.789 |
|
| 2014 |
Petrilli A, Copik A, Posadas M, Chang LS, Welling DB, Giovannini M, Fernández-Valle C. LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2. Oncogene. 33: 3571-82. PMID 23934191 DOI: 10.1038/onc.2013.320 |
0.365 |
|
| 2014 |
Vitte J, Chareyre F, Stemmer-Rachamimov A, Judkins A, Giovannini M. Conditional Inactivation of SMARCB1 in P0 Permissive Mouse Cells Generates Rhabdoid Tumors in the Peripheral Nervous System Cancer Genetics. 207: 451. DOI: 10.1016/J.Cancergen.2014.09.023 |
0.759 |
|
| 2013 |
Lavado A, He Y, Paré J, Neale G, Olson EN, Giovannini M, Cao X. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators. Development (Cambridge, England). 140: 3323-34. PMID 23863479 DOI: 10.1242/Dev.096537 |
0.448 |
|
| 2013 |
Tanaka K, Eskin A, Chareyre F, Jessen WJ, Manent J, Niwa-Kawakita M, Chen R, White CH, Vitte J, Jaffer ZM, Nelson SF, Rubenstein AE, Giovannini M. Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 3856-70. PMID 23714726 DOI: 10.1158/1078-0432.Ccr-12-3167 |
0.736 |
|
| 2013 |
Schulz A, Baader SL, Niwa-Kawakita M, Jung MJ, Bauer R, Garcia C, Zoch A, Schacke S, Hagel C, Mautner VF, Hanemann CO, Dun XP, Parkinson DB, Weis J, Schröder JM, ... ... Giovannini M, et al. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy. Nature Neuroscience. 16: 426-33. PMID 23455610 DOI: 10.1038/Nn.3348 |
0.456 |
|
| 2013 |
Plotkin SR, Blakeley JO, Evans DG, Hanemann CO, Hulsebos TJ, Hunter-Schaedle K, Kalpana GV, Korf B, Messiaen L, Papi L, Ratner N, Sherman LS, Smith MJ, Stemmer-Rachamimov AO, Vitte J, ... Giovannini M, et al. Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria. American Journal of Medical Genetics. Part A. 161: 405-16. PMID 23401320 DOI: 10.1002/Ajmg.A.35760 |
0.781 |
|
| 2013 |
Jessen WJ, Miller SJ, Jousma E, Wu J, Rizvi TA, Brundage ME, Eaves D, Widemann B, Kim MO, Dombi E, Sabo J, Hardiman Dudley A, Niwa-Kawakita M, Page GP, Giovannini M, et al. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. The Journal of Clinical Investigation. 123: 340-7. PMID 23221341 DOI: 10.1172/Jci60578 |
0.478 |
|
| 2013 |
Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C, Volk A, Niwa-Kawakita M, Karboul N, Giovannini M, Kalamarides M. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation Oncogene. 32: 4264-4272. PMID 23045274 DOI: 10.1038/Onc.2012.436 |
0.482 |
|
| 2013 |
Lavado A, He Y, Pare J, Neale G, Olson EN, Giovannini M, Cao X. Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators Journal of Cell Science. 126: e1-e1. DOI: 10.1242/jcs.138818 |
0.348 |
|
| 2012 |
Pei Y, Brun SN, Markant SL, Lento W, Gibson P, Taketo MM, Giovannini M, Gilbertson RJ, Wechsler-Reya RJ. WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development (Cambridge, England). 139: 1724-33. PMID 22461560 DOI: 10.1242/Dev.050104 |
0.327 |
|
| 2012 |
Blakeley JO, Evans DG, Adler J, Brackmann D, Chen R, Ferner RE, Hanemann CO, Harris G, Huson SM, Jacob A, Kalamarides M, Karajannis MA, Korf BR, Mautner VF, McClatchey AI, ... ... Giovannini M, et al. Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2. American Journal of Medical Genetics. Part A. 158: 24-41. PMID 22140088 DOI: 10.1002/Ajmg.A.34359 |
0.469 |
|
| 2011 |
Yogesha SD, Sharff AJ, Giovannini M, Bricogne G, Izard T. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor. Protein Science : a Publication of the Protein Society. 20: 2113-20. PMID 22012890 DOI: 10.1002/Pro.751 |
0.445 |
|
| 2011 |
Cooper J, Li W, You L, Schiavon G, Pepe-Caprio A, Zhou L, Ishii R, Giovannini M, Hanemann CO, Long SB, Erdjument-Bromage H, Zhou P, Tempst P, Giancotti FG. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression. Science Signaling. 4: pt6. PMID 21878678 DOI: 10.1126/Scisignal.2002314 |
0.498 |
|
| 2011 |
Jean D, Thomas E, Manié E, Renier A, de Reynies A, Lecomte C, Andujar P, Fleury-Feith J, Galateau-Sallé F, Giovannini M, Zucman-Rossi J, Stern MH, Jaurand MC. Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma. The American Journal of Pathology. 178: 881-94. PMID 21281820 DOI: 10.1016/J.Ajpath.2010.10.039 |
0.337 |
|
| 2011 |
Huson SM, Acosta MT, Belzberg AJ, Bernards A, Chernoff J, Cichowski K, Gareth Evans D, Ferner RE, Giovannini M, Korf BR, Listernick R, North KN, Packer RJ, Parada LF, Peltonen J, et al. Back to the future: proceedings from the 2010 NF Conference. American Journal of Medical Genetics. Part A. 155: 307-21. PMID 21271647 DOI: 10.1002/Ajmg.A.33804 |
0.468 |
|
| 2011 |
Kalamarides M, Stemmer-Rachamimov AO, Niwa-Kawakita M, Chareyre F, Taranchon E, Han ZY, Martinelli C, Lusis EA, Hegedus B, Gutmann DH, Giovannini M. Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene. 30: 2333-44. PMID 21242963 DOI: 10.1038/Onc.2010.609 |
0.364 |
|
| 2011 |
Peyre M, Stemmer-Rachamimov A, Taranchon E, Niwa-Kawakita M, Quentin S, Giovannini M, Kalamarides M. Coopération de NF2 et CDKN2AB dans un modèle murin transgénique de méningiome de grade 2/3 Neurochirurgie. 57: 267. DOI: 10.1016/J.Neuchi.2011.09.055 |
0.323 |
|
| 2010 |
Kalamarides M, Peyre M, Giovannini M. Meningioma mouse models. Journal of Neuro-Oncology. 99: 325-31. PMID 20734219 DOI: 10.1007/S11060-010-0331-5 |
0.46 |
|
| 2010 |
Goutagny S, Yang HW, Zucman-Rossi J, Chan J, Dreyfuss JM, Park PJ, Black PM, Giovannini M, Carroll RS, Kalamarides M. Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4155-64. PMID 20682713 DOI: 10.1158/1078-0432.Ccr-10-0891 |
0.405 |
|
| 2010 |
Benhamouche S, Curto M, Saotome I, Gladden AB, Liu CH, Giovannini M, McClatchey AI. Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver. Genes & Development. 24: 1718-30. PMID 20675406 DOI: 10.1101/Gad.1938710 |
0.366 |
|
| 2010 |
Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J, Giovannini M, Liu P, Anders RA, Pan D. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Developmental Cell. 19: 27-38. PMID 20643348 DOI: 10.1016/J.Devcel.2010.06.015 |
0.442 |
|
| 2010 |
Wiley LA, Dattilo LK, Kang KB, Giovannini M, Beebe DC. The tumor suppressor merlin is required for cell cycle exit, terminal differentiation, and cell polarity in the developing murine lens. Investigative Ophthalmology & Visual Science. 51: 3611-8. PMID 20181838 DOI: 10.1167/Iovs.09-4371 |
0.492 |
|
| 2010 |
Li W, You L, Cooper J, Schiavon G, Pepe-Caprio A, Zhou L, Ishii R, Giovannini M, Hanemann CO, Long SB, Erdjument-Bromage H, Zhou P, Tempst P, Giancotti FG. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell. 140: 477-90. PMID 20178741 DOI: 10.1016/J.Cell.2010.01.029 |
0.476 |
|
| 2009 |
Miller SJ, Jessen WJ, Mehta T, Hardiman A, Sites E, Kaiser S, Jegga AG, Li H, Upadhyaya M, Giovannini M, Muir D, Wallace MR, Lopez E, Serra E, Nielsen GP, et al. Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene. Embo Molecular Medicine. 1: 236-48. PMID 20049725 DOI: 10.1002/Emmm.200900027 |
0.42 |
|
| 2009 |
Lallemand D, Saint-Amaux AL, Giovannini M. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. Journal of Cell Science. 122: 4141-9. PMID 19910496 DOI: 10.1242/Jcs.045914 |
0.384 |
|
| 2009 |
Evans DG, Kalamarides M, Hunter-Schaedle K, Blakeley J, Allen J, Babovic-Vuskanovic D, Belzberg A, Bollag G, Chen R, DiTomaso E, Golfinos J, Harris G, Jacob A, Kalpana G, Karajannis M, ... ... Giovannini M, et al. Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5032-9. PMID 19671848 DOI: 10.1158/1078-0432.Ccr-08-3011 |
0.466 |
|
| 2009 |
Lee TX, Packer MD, Huang J, Akhmametyeva EM, Kulp SK, Chen CS, Giovannini M, Jacob A, Welling DB, Chang LS. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells. European Journal of Cancer (Oxford, England : 1990). 45: 1709-20. PMID 19359162 DOI: 10.1016/J.Ejca.2009.03.013 |
0.317 |
|
| 2009 |
Mercher T, Raffel GD, Moore SA, Cornejo MG, Baudry-Bluteau D, Cagnard N, Jesneck JL, Pikman Y, Cullen D, Williams IR, Akashi K, Shigematsu H, Bourquin JP, Giovannini M, Vainchenker W, et al. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. The Journal of Clinical Investigation. 119: 852-64. PMID 19287095 DOI: 10.1172/Jci35901 |
0.353 |
|
| 2009 |
Coulpier F, Le Crom S, Maro GS, Manent J, Giovannini M, Maciorowski Z, Fischer A, Gessler M, Charnay P, Topilko P. Novel features of boundary cap cells revealed by the analysis of newly identified molecular markers. Glia. 57: 1450-7. PMID 19243017 DOI: 10.1002/Glia.20862 |
0.327 |
|
| 2009 |
Houshmandi SS, Emnett RJ, Giovannini M, Gutmann DH. The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner. Molecular and Cellular Biology. 29: 1472-86. PMID 19103750 DOI: 10.1128/Mcb.01392-08 |
0.375 |
|
| 2009 |
Lallemand D, Manent J, Couvelard A, Watilliaux A, Siena M, Chareyre F, Lampin A, Niwa-Kawakita M, Kalamarides M, Giovannini M. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene. 28: 854-865. PMID 19029950 DOI: 10.1038/Onc.2008.427 |
0.372 |
|
| 2008 |
Denisenko N, Cifuentes-Diaz C, Irinopoulou T, Carnaud M, Benoit E, Niwa-Kawakita M, Chareyre F, Giovannini M, Girault JA, Goutebroze L. Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 10472-81. PMID 18923024 DOI: 10.1523/Jneurosci.2537-08.2008 |
0.415 |
|
| 2008 |
Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, Glickman JN, Niwa-Kawakita M, Sweet-Cordero A, Sebolt-Leopold J, Shannon KM, Settleman J, Giovannini M, Jacks T. Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nature Genetics. 40: 600-8. PMID 18372904 DOI: 10.1038/Ng.115 |
0.334 |
|
| 2008 |
Ramos OHP, Kauskot A, Cominetti MR, Bechyne I, Pontes CLS, Chareyre F, Manent J, Vassy R, Giovannini M, Legrand C, Selistre-de-Araujo HS, Crépin M, Bonnefoy A. A novel αvβ3-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis Clinical & Experimental Metastasis. 25: 53-64. PMID 17952617 DOI: 10.1007/S10585-007-9101-Y |
0.323 |
|
| 2008 |
Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M, Black PM, Carroll RS, Giovannini M. Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathology (Zurich, Switzerland). 18: 62-70. PMID 17924978 DOI: 10.1111/J.1750-3639.2007.00105.X |
0.501 |
|
| 2008 |
Mercher T, Raffel GD, Moore SA, Cornejo MG, Baudry-Bluteau D, Cagnard N, Jesneck J, Pikman Y, Cullen DE, Williams I, Akashi K, Shigematsu H, Bourquin J, Giovannini M, Vainchenker W, et al. OTT-MAL Activates the Notch Signaling Transcription Factor RBPJ and Cooperates with Mutant MPL to Induce Acute Megakaryoblastic Leukemia Blood. 112: 508-508. DOI: 10.1182/Blood.V112.11.508.508 |
0.387 |
|
| 2007 |
Muranen T, Grönholm M, Lampin A, Lallemand D, Zhao F, Giovannini M, Carpén O. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton Human Molecular Genetics. 16: 1742-1751. PMID 17566081 DOI: 10.1093/Hmg/Ddm122 |
0.389 |
|
| 2006 |
Messerli SM, Prabhakar S, Tang Y, Mahmood U, Giovannini M, Weissleder R, Bronson R, Martuza R, Rabkin S, Breakefield XO. Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2. Human Gene Therapy. 17: 20-30. PMID 16409122 DOI: 10.1089/Hum.2006.17.20 |
0.435 |
|
| 2005 |
Lecomte C, Andujar P, Renier A, Kheuang L, Abramowski V, Mellottee L, Fleury-Feith J, Zucman-Rossi J, Giovannini M, Jaurand MC. Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma. Cell Cycle (Georgetown, Tex.). 4: 1862-9. PMID 16319530 DOI: 10.4161/Cc.4.12.2300 |
0.449 |
|
| 2005 |
McClatchey AI, Giovannini M. Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin. Genes & Development. 19: 2265-77. PMID 16204178 DOI: 10.1101/Gad.1335605 |
0.461 |
|
| 2004 |
Robanus-Maandag E, Giovannini M, Van Der Valk M, Niwa-Kawakita M, Abramowski V, Antonescu C, Thomas G, Berns A. Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin Oncogene. 23: 6541-6547. PMID 15221010 DOI: 10.1038/Sj.Onc.1207858 |
0.708 |
|
| 2004 |
Stemmer-Rachamimov AO, Louis DN, Nielsen GP, Antonescu CR, Borowsky AD, Bronson RT, Burns DK, Cervera P, McLaughlin ME, Reifenberger G, Schmale MC, MacCollin M, Chao RC, Cichowski K, Kalamarides M, ... ... Giovannini M, et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Research. 64: 3718-24. PMID 15150133 DOI: 10.1158/0008-5472.Can-03-4079 |
0.461 |
|
| 2004 |
Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M, Xiao GH, Testa JR, Wood J, Maruta H. A clue to the therapy of neurofibromatosis type 2: NF2/Merlin is a PAK inhibitor Cancer Journal. 10: 20-25. PMID 15000491 DOI: 10.1097/00130404-200401000-00006 |
0.464 |
|
| 2003 |
Fleury-Feith J, Lecomte C, Renier A, Matrat M, Kheuang L, Abramowski V, Levy F, Janin A, Giovannini M, Jaurand M. Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene. 22: 3799-3805. PMID 12802287 DOI: 10.1038/Sj.Onc.1206593 |
0.451 |
|
| 2003 |
Gutmann DH, Baker SJ, Giovannini M, Garbow J, Weiss W. Mouse models of human cancer consortium symposium on nervous system tumors. Cancer Research. 63: 3001-4. PMID 12782610 |
0.337 |
|
| 2003 |
Lallemand D, Curto M, Saotome I, Giovannini M, McClatchey AI. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes & Development. 17: 1090-100. PMID 12695331 DOI: 10.1101/Gad.1054603 |
0.469 |
|
| 2003 |
Utermark T, Alekov A, Lerche H, Abramowski V, Giovannini M, Hanemann CO. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells. Cancer. 97: 1955-62. PMID 12673723 DOI: 10.1002/Cncr.11275 |
0.477 |
|
| 2003 |
Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F, Bui TH, Giovannini M, Zaehringer U, Penard-Lacronique V, Sansonetti PJ, Hugot JP, Thomas G. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proceedings of the National Academy of Sciences of the United States of America. 100: 3455-60. PMID 12626759 DOI: 10.1073/Pnas.0530276100 |
0.538 |
|
| 2003 |
Manent J, Oguievetskaia K, Bayer J, Ratner N, Giovannini M. Magnetic cell sorting for enriching Schwann cells from adult mouse peripheral nerves. Journal of Neuroscience Methods. 123: 167-73. PMID 12606065 DOI: 10.1016/S0165-0270(02)00349-7 |
0.319 |
|
| 2003 |
Leneuve P, Colnot S, Hamard G, Francis F, Niwa-Kawakita M, Giovannini M, Holzenberger M. Cre-mediated germline mosaicism: a new transgenic mouse for the selective removal of residual markers from tri-lox conditional alleles. Nucleic Acids Research. 31: e21. PMID 12595570 DOI: 10.1093/Nar/Gng021 |
0.303 |
|
| 2002 |
Sun CX, Haipek C, Scoles DR, Pulst SM, Giovannini M, Komada M, Gutmann DH. Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate. Human Molecular Genetics. 11: 3167-78. PMID 12444101 DOI: 10.1093/Hmg/11.25.3167 |
0.376 |
|
| 2002 |
Messerli SM, Tang Y, Giovannini M, Bronson R, Weissleder R, Breakefield XO. Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2. Neoplasia (New York, N.Y.). 4: 501-9. PMID 12407444 DOI: 10.1038/Sj.Neo.7900265 |
0.451 |
|
| 2002 |
Weiss WA, Israel M, Cobbs C, Holland E, James CD, Louis DN, Marks C, McClatchey AI, Roberts T, Van Dyke T, Wetmore C, Chiu IM, Giovannini M, Guha A, Higgins RJ, et al. Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene. 21: 7453-63. PMID 12386807 DOI: 10.1038/Sj.Onc.1205936 |
0.451 |
|
| 2002 |
Gautreau A, Manent J, Fievet B, Louvard D, Giovannini M, Arpin M. Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway. The Journal of Biological Chemistry. 277: 31279-82. PMID 12130630 DOI: 10.1074/Jbc.C200125200 |
0.382 |
|
| 2002 |
Gutmann DH, Giovannini M. Mouse models of neurofibromatosis 1 and 2 Neoplasia. 4: 279-290. PMID 12082543 DOI: 10.1038/Sj.Neo.7900249 |
0.532 |
|
| 2002 |
Kalamarides M, Niwa-Kawakita M, Leblois H, Abramowski V, Perricaudet M, Janin A, Thomas G, Gutmann DH, Giovannini M. Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes & Development. 16: 1060-5. PMID 12000789 DOI: 10.1101/Gad.226302 |
0.673 |
|
| 2000 |
Lim DJ, Rubenstein AE, Evans DG, Jacks T, Seizinger BG, Baser ME, Beebe D, Brackmann DE, Chiocca EA, Fehon RG, Giovannini M, Glazer R, Gusella JF, Gutmann DH, Korf B, et al. Advances in neurofibromatosis 2 (NF2): a workshop report. Journal of Neurogenetics. 14: 63-106. PMID 10992163 DOI: 10.3109/01677060009083477 |
0.365 |
|
| 2000 |
Niwa-Kawakita M, Abramowski V, Kalamarides M, Thomas G, Giovannini M. Targeted expression of Cre recombinase to myelinating cells of the central nervous system in transgenic mice Genesis. 26: 127-129. PMID 10686606 DOI: 10.1002/(Sici)1526-968X(200002)26:2<127::Aid-Gene8>3.0.Co;2-H |
0.515 |
|
| 2000 |
Carron C, Cormier F, Janin A, Lacronique V, Giovannini M, Daniel M, Bernard O, Ghysdael J. TEL-JAK2 transgenic mice develop T-cell leukemia. Blood. 95: 3891-3899. DOI: 10.1182/Blood.V95.12.3891.012K13_3891_3899 |
0.317 |
|
| 2000 |
Giovannini M, Robanus-Maandag E, Valk Mvd, Niwa-Kawakita M, Abramowski V, Goutebroze L, Woodruff JM, Berns A, Thomas G. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2 Genes & Development. 14: 1617-1630. DOI: 10.1101/Gad.14.13.1617 |
0.66 |
|
| 1999 |
Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, van der Valk M, Woodruff JM, Goutebroze L, Mérel P, Berns A, Thomas G. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes & Development. 13: 978-86. PMID 10215625 DOI: 10.1101/Gad.13.8.978 |
0.644 |
|
| 1998 |
Deguen B, Goutebroze L, Giovannini M, Boisson C, Neut Rvd, Jaurand M, Thomas G. Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. International Journal of Cancer. 77: 554-560. PMID 9679758 DOI: 10.1002/(Sici)1097-0215(19980812)77:4<554::Aid-Ijc14>3.0.Co;2-6 |
0.64 |
|
| 1997 |
Akagi K, Sandig V, Vooijs M, Valk MVd, Giovannini M, Strauss M, Berns A. Cre-mediated somatic site-specific recombination in mice Nucleic Acids Research. 25: 1766-1773. PMID 9108159 DOI: 10.1093/Nar/25.9.1766 |
0.3 |
|
| 1996 |
Thomas G, Merel P, Giovannini M, Niwa-Kawakita M, Robanus-Maandag E, Berns A, Goutebrose L, Deguen B. The NF2 tumor suppressor gene Cancer Genetics and Cytogenetics. 91: 110. DOI: 10.1016/S0165-4608(97)82511-3 |
0.654 |
|
| 1994 |
Ruttledge MH, Xie Y, Han F, Giovannini M, Janson M, Fransson I, Werelius B, Delattre O, Thomas G, Evans G, Dumanski JP. Physical mapping of the NF2/meningioma region on human chromosome 22q12. Genomics. 19: 52-59. PMID 8188242 DOI: 10.1006/Geno.1994.1012 |
0.692 |
|
| 1994 |
Giovannini M, Biegel JA, Serra M, Wang JY, Wei YH, Nycum L, Emanuel BS, Evans GA. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations Journal of Clinical Investigation. 94: 489-496. PMID 8040301 DOI: 10.1172/Jci117360 |
0.671 |
|
| 1994 |
Selleri L, Giovannini M, Romo A, Zucman J, Delattre O, Thomas G, Evans GA. Cloning of the entire FLI1 gene, disrupted by the Ewing's sarcoma translocation breakpoint on 11q24, in a yeast artificial chromosome. Cytogenetic and Genome Research. 67: 129-136. PMID 8039423 DOI: 10.1159/000133813 |
0.606 |
|
| 1994 |
Selleri L, Giovannini M, Hermanson GG, Romo A, Quackenbush J, Penny L, Khristich JV, Evans GA. Yeast Artificial Chromosome Cloning of 3.2 Megabases within Chromosomal Band 11q24 Closely Linking c-ets 1 and Fli-1 and Encompassing the Ewing Sarcoma Breakpoint Genomics. 22: 137-147. PMID 7959760 DOI: 10.1006/Geno.1994.1354 |
0.607 |
|
| 1993 |
Giovannini M, Romo AJ, Evans GA. Chromosomal localization of the human ciliary neurotrophic factor gene (CNTF) to 11 q12 by fluorescence in situ hybridization Cytogenetic and Genome Research. 63: 62-63. PMID 8449041 DOI: 10.1159/000133504 |
0.608 |
|
| 1993 |
Giovannini M, Selleri L, Hermanson GG, Evans GA. Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint. Cytogenetics and Cell Genetics. 62: 32-4. PMID 8422753 DOI: 10.1159/000133439 |
0.61 |
|
| 1993 |
Giovannini M, Djabali M, McElligott D, Selleri L, Evans GA. Tandem linkage of genes coding for leukemia inhibitory factor (LIF) and oncostatin M (OSM) on human chromosome 22 Cytogenetic and Genome Research. 64: 240-244. PMID 8404048 DOI: 10.1159/000133586 |
0.605 |
|
| 1993 |
Giovannini M, Selleri L, Evans GA. Fluorescent in situ hybridization for the detection of the t(11;22)(q24;q12) in small round cell tumors Cancer Genetics and Cytogenetics. 66: 167. DOI: 10.1016/0165-4608(93)90352-M |
0.622 |
|
| 1992 |
Giovannini M, Selleri L, Biegel JA, Scotlandi K, Emanuel BS, Evans GA. Interphase cytogenetics for the detection of the t(11;22)(q24;q12) in small round cell tumors Journal of Clinical Investigation. 90: 1911-1918. PMID 1430213 DOI: 10.1172/Jci116068 |
0.666 |
|
| 1992 |
Selleri L, Eubanks JH, Giovannini M, Hermanson GG, Romo A, Djabali M, Maurer S, McElligott DL, Smith MW, Evans GA. Detection and characterization of "chimeric" yeast artificial chromosome clones by fluorescent in situ suppression hybridization. Genomics. 14: 536-41. PMID 1427876 DOI: 10.1016/S0888-7543(05)80263-0 |
0.579 |
|
| 1992 |
Selleri L, Giovannini M, Hermanson GG, Romo A, Serra M, Djabali M, Evans GA. Molecular characterization of the (11;22)(q24;q12) translocation of Ewing's sarcoma: Isolation of new diagnostic probes on 11q24–q25 for FISSH Cancer Genetics and Cytogenetics. 63: 162. DOI: 10.1016/0165-4608(92)90502-Y |
0.579 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2009 |
Boulday G, Blécon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, Giovannini M, Tournier-Lasserve E. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: implications for human cerebral cavernous malformations. Disease Models & Mechanisms. 2: 168-77. PMID 19259391 DOI: 10.1242/Dmm.001263 |
0.3 |
|
| 2006 |
Messerli S, Prabhakar S, Tang Y, Mahmood U, Giovannini M, Weissleder R, Bronson R, Martuza R, Rabkin S, Breakefield XO. Erratum: Treatment of schwannomas with an oncolytic recombinant herpes simplex virus in murine models of neurofibromatosis type 2 (Human Gene Therapy (January 2006) 17, 1 (20-30)) Human Gene Therapy. 17. DOI: 10.1089/Hum.2006.17.796 |
0.297 |
|
| 2007 |
Morrison H, Sperka T, Manent J, Giovannini M, Ponta H, Herrlich P. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac. Cancer Research. 67: 520-7. PMID 17234759 DOI: 10.1158/0008-5472.Can-06-1608 |
0.285 |
|
| 2003 |
Berrebi D, Maudinas R, Hugot JP, Chamaillard M, Chareyre F, De Lagausie P, Yang C, Desreumaux P, Giovannini M, Cézard JP, Zouali H, Emilie D, Peuchmaur M. Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn's disease colon. Gut. 52: 840-6. PMID 12740340 DOI: 10.1136/Gut.52.6.840 |
0.269 |
|
| 2008 |
Meinzer U, Esmiol-Welterlin S, Barreau F, Berrebi D, Dussaillant M, Bonacorsi S, Chareyre F, Niwa-Kawakita M, Alberti C, Sterkers G, Villard C, Lesuffleur T, Peuchmaur M, Karin M, Eckmann L, ... Giovannini M, et al. Nod2 mediates susceptibility to Yersinia pseudotuberculosis in mice. Plos One. 3: e2769. PMID 18648508 DOI: 10.1371/Journal.Pone.0002769 |
0.268 |
|
| 2007 |
Barreau F, Meinzer U, Chareyre F, Berrebi D, Niwa-Kawakita M, Dussaillant M, Foligne B, Ollendorff V, Heyman M, Bonacorsi S, Lesuffleur T, Sterkers G, Giovannini M, Hugot JP. CARD15/NOD2 is required for Peyer's patches homeostasis in mice. Plos One. 2: e523. PMID 17565376 DOI: 10.1371/Journal.Pone.0000523 |
0.265 |
|
| 2004 |
Colnot S, Decaens T, Niwa-Kawakita M, Godard C, Hamard G, Kahn A, Giovannini M, Perret C. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proceedings of the National Academy of Sciences of the United States of America. 101: 17216-21. PMID 15563600 DOI: 10.1073/Pnas.0404761101 |
0.264 |
|
| 2005 |
Magalhaes JG, Philpott DJ, Nahori MA, Jéhanno M, Fritz J, Le Bourhis L, Viala J, Hugot JP, Giovannini M, Bertin J, Lepoivre M, Mengin-Lecreulx D, Sansonetti PJ, Girardin SE. Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. Embo Reports. 6: 1201-7. PMID 16211083 DOI: 10.1038/Sj.Embor.7400552 |
0.249 |
|
| 2015 |
Fang F, Sun S, Wang L, Guan JL, Giovannini M, Zhu Y, Liu F. Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 1195-205. PMID 25639352 DOI: 10.1002/Jbmr.2447 |
0.243 |
|
| 2007 |
Boneca IG, Dussurget O, Cabanes D, Nahori MA, Sousa S, Lecuit M, Psylinakis E, Bouriotis V, Hugot JP, Giovannini M, Coyle A, Bertin J, Namane A, Rousselle JC, Cayet N, et al. A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proceedings of the National Academy of Sciences of the United States of America. 104: 997-1002. PMID 17215377 DOI: 10.1073/Pnas.0609672104 |
0.243 |
|
| 2004 |
Colnot S, Niwa-Kawakita M, Hamard G, Godard C, Plenier SL, Houbron C, Romagnolo B, Berrebi D, Giovannini M, Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Laboratory Investigation. 84: 1619-1630. PMID 15502862 DOI: 10.1038/Labinvest.3700180 |
0.24 |
|
| 2011 |
Cifuentes-Diaz C, Chareyre F, Garcia M, Devaux J, Carnaud M, Levasseur G, Niwa-Kawakita M, Harroch S, Girault JA, Giovannini M, Goutebroze L. Protein 4.1B contributes to the organization of peripheral myelinated axons. Plos One. 6: e25043. PMID 21966409 DOI: 10.1371/Journal.Pone.0025043 |
0.236 |
|
| 2015 |
Klingler E, Martin PM, Garcia M, Moreau-Fauvarque C, Falk J, Chareyre F, Giovannini M, Chédotal A, Girault JA, Goutebroze L. The cytoskeleton-associated protein SCHIP1 is involved in axon guidance, and is required for piriform cortex and anterior commissure development. Development (Cambridge, England). 142: 2026-36. PMID 25953347 DOI: 10.1242/Dev.119248 |
0.236 |
|
| 2003 |
Denisenko-Nehrbass N, Goutebroze L, Galvez T, Bonnon C, Stankoff B, Ezan P, Giovannini M, Faivre-Sarrailh C, Girault JA. Association of Caspr/paranodin with tumour suppressor schwannomin/merlin and beta1 integrin in the central nervous system. Journal of Neurochemistry. 84: 209-21. PMID 12558984 DOI: 10.1046/J.1471-4159.2003.01503.X |
0.236 |
|
| 2008 |
Perrotti AP, Niscola P, Tendas A, Scaramucci L, Palombi M, Cupelli L, Dentamaro T, Piccioni D, Giovannini M, Fabritis Pd. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin’s lymphoma patients Annals of Hematology. 87: 493-494. PMID 18074132 DOI: 10.1007/S00277-007-0423-2 |
0.235 |
|
| 2008 |
Body-Malapel M, Dharancy S, Berrebi D, Louvet A, Hugot JP, Philpott DJ, Giovannini M, Chareyre F, Pages G, Gantier E, Girardin SE, Garcia I, Hudault S, Conti F, Sansonetti PJ, et al. NOD2: a potential target for regulating liver injury. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 318-27. PMID 18227809 DOI: 10.1038/Labinvest.3700716 |
0.231 |
|
| 2006 |
Niscola P, Romani C, Perrotti AP, Poeta GD, Cartoni C, Palombi M, Giovannini M, Cupelli L, Fabritiis PD. Acute Zoster Pain (AZP) and Post-Herpetic Neuralgia (PHN) in the Course of Lymphoproliferative Disorders (LPD): Durable Pain Relief Provided by Oxycodone in Patients Unresponsive to Standard Therapy. Blood. 108: 5500-5500. DOI: 10.1182/Blood.V108.11.5500.5500 |
0.229 |
|
| 2006 |
Harmache A, LeBerre M, Droineau S, Giovannini M, Brémont M. Bioluminescence imaging of live infected salmonids reveals that the fin bases are the major portal of entry for Novirhabdovirus. Journal of Virology. 80: 3655-9. PMID 16537634 DOI: 10.1128/Jvi.80.7.3655-3659.2006 |
0.229 |
|
| 2007 |
Goutagny S, Chan RCJ, Giovannini M, Black PM, Kalamarides M. Identification des altérations génétiques impliquées dans la progression maligne des méningiomes Neurochirurgie. 53: 424-425. DOI: 10.1016/J.Neuchi.2007.09.037 |
0.227 |
|
| 2014 |
Niscola P, Tendas A, Scaramucci L, Giovannini M. End of life care in hematology: still a challenging concern. Annals of Palliative Medicine. 3: 7-11. PMID 25841481 DOI: 10.3978/J.Issn.2224-5820.2013.12.02 |
0.226 |
|
| 2006 |
Niscola P, Cupelli L, Romani C, Cartoni C, Piccioni D, Dentamaro T, Neri B, Tendas A, Giovannini M, Maurillo L, Amadori S, Fabritiis PD. Epidemiology and Characteristics of Pain in Blood-Related Disorders: A Longitudinal Study on Italian Adult Hospitalized Patients. Blood. 108: 5501-5501. DOI: 10.1182/Blood.V108.11.5501.5501 |
0.223 |
|
| 2018 |
Niscola P, Scaramucci L, Giovannini M. Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia. Immunotherapy. 10: 5-7. PMID 29192558 DOI: 10.2217/Imt-2017-0141 |
0.222 |
|
| 2006 |
Niscola P, Cartoni C, Romani C, Giovannini M, Brunetti G, D’Elia GM, Cupelli L, Fabritiis PD, Foà R, Mandelli F. Epidemiology and Characteristics of Pain in Patients Suffering from Advanced Haematological Malignancies in the Home Care (HC) Setting: An Italian Survey. Blood. 108: 5502-5502. DOI: 10.1182/Blood.V108.11.5502.5502 |
0.221 |
|
| 2016 |
Brunetti GA, Palumbo G, Morano GS, Baldacci E, Carmosino I, Annechini G, Talone R, Kiflom S, Mastrogiacomo G, Grammatico S, Chisini M, Costa A, Tendas A, Scaramucci L, Giovannini M, et al. Tapentadol PR for pain syndromes in real life patients with hematological malignancy. Cardiovascular & Hematological Agents in Medicinal Chemistry. PMID 27048320 DOI: 10.2174/1871525714666160405110833 |
0.209 |
|
| 2011 |
Niscola P, Tendas A, Scaramucci L, Giovannini M, De Sanctis V. Pain in blood cancers. Indian Journal of Palliative Care. 17: 175-83. PMID 22346041 DOI: 10.4103/0973-1075.92333 |
0.209 |
|
| 2011 |
Robanus-Maandag E, Bosch C, Amini-Nik S, Knijnenburg J, Szuhai K, Cervera P, Poon R, Eccles D, Radice P, Giovannini M, Alman BA, Tejpar S, Devilee P, Fodde R. Familial adenomatous polyposis-associated desmoids display significantly more genetic changes than sporadic desmoids. Plos One. 6: e24354. PMID 21931686 DOI: 10.1371/Journal.Pone.0024354 |
0.208 |
|
| 2011 |
Duflocq A, Chareyre F, Giovannini M, Couraud F, Davenne M. Characterization of the axon initial segment (AIS) of motor neurons and identification of a para-AIS and a juxtapara-AIS, organized by protein 4.1B. Bmc Biology. 9: 66. PMID 21958379 DOI: 10.1186/1741-7007-9-66 |
0.205 |
|
| 2007 |
Kauskot A, Manent J, Chareyre F, Cominetti M, Chopin M, Giovannini M, Legrand C, Bonnefoy A. L'imagerie par bioluminescence pour visualiser la progression tumorale et la métastase chez le petit animal Biologie Aujourd'Hui. 201: 223-228. PMID 18157073 DOI: 10.1051/Jbio:2007032 |
0.201 |
|
| 2021 |
Ishan M, Chen G, Yu W, Wang Z, Giovannini M, Cao X, Liu HX. Deletion of Nf2 in neural crest-derived tongue mesenchyme alters tongue shape and size, Hippo signalling and cell proliferation in a region- and stage-specific manner. Cell Proliferation. e13144. PMID 34697858 DOI: 10.1111/cpr.13144 |
0.192 |
|
| 2007 |
Andujar P, Lecomte C, Renier A, Kheuang L, Janin A, Fleury-Feith J, Giovannini M, Jaurand MC. 037 Les mésothéliomes malins murins induits par les fibres céramiques réfractaires ont des profils d’altérations génétiques similaires à ceux induits par l’amiante Revue Des Maladies Respiratoires. 24: 1208-1208. DOI: 10.1016/S0761-8425(07)74328-0 |
0.192 |
|
| 2016 |
Scaramucci L, Niscola P, Palombi M, Tendas A, Giovannini M, Fabritiis Pd. Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency. Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology. 33: 77-8. PMID 27091587 DOI: 10.4274/Tjh.2015.0181 |
0.184 |
|
| 2008 |
Kalamarides M, Stemmer-Rachamimov AO, Chareyre F, Niwa-Kawakita M, Giovannini M. Identifier la cellule arachnoïdienne progénitrice des méningiomes : intérêt des modèles animaux Neurochirurgie. 54: 678. DOI: 10.1016/J.Neuchi.2008.08.038 |
0.183 |
|
| 1996 |
Romano V, Guldberg P, Güttler F, Meli C, Mollica F, Pavone L, Giovannini M, Riva E, Biasucci G, Luotti D, Palillo L, Calí F, Ceratto N, Anello G, Bosco P. PAH deficiency in Italy: correlation of genotype with phenotype in the Sicilian population. Journal of Inherited Metabolic Disease. 19: 15-24. PMID 8830172 DOI: 10.1007/BF01799343 |
0.152 |
|
| 2003 |
Crone SA, Negro A, Trumpp A, Giovannini M, Lee KF. Colonic epithelial expression of ErbB2 is required for postnatal maintenance of the enteric nervous system. Neuron. 37: 29-40. PMID 12526770 DOI: 10.1016/S0896-6273(02)01128-5 |
0.13 |
|
| 2013 |
Tendas A, Niscola P, Scaramucci L, Giovannini M, Cupelli L, Trawinska MM, Siniscalchi A, Abruzzese E, Caravita T, Palombi M, Dentamaro T, Perrotti A, de Fabritiis P. Dysgeusia in patients with hematological malignancies: a reminder for hematologist. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 42: 352-3. PMID 23278835 DOI: 10.1111/jop.12034 |
0.128 |
|
| 2023 |
Niscola P, Mazzone C, Fratoni S, Ardu NR, Cesini L, Giovannini M, Ottone T, Anemona L, Voso MT, de Fabritiis P. Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax/azacytidine combination in a very old patient. Acta Haematologica. 1. PMID 37231772 DOI: 10.1159/000531101 |
0.127 |
|
| 2024 |
Niscola P, Gianfelici V, Giovannini M, Piccioni D, Mazzone C, Fabritiis P. Very long-term efficacy of venetoclax combined with hypomethylating agents in two AML elderly: is it the time for treatment discontinuation strategies? Annals of Hematology. PMID 38459155 DOI: 10.1007/s00277-024-05700-4 |
0.12 |
|
| 2014 |
Niscola P, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P. Diagnosis of myelodysplastic syndromes in individuals heterozygous for mutations in the α- and β-globin genes: a reminder for haematologists. Blood Transfusion = Trasfusione Del Sangue. 12: s158-9. PMID 24120582 DOI: 10.2450/2013.0083-13 |
0.113 |
|
| 2009 |
Niscola P, Scaramucci L, Giovannini M, Ales M, Bondanini F, Cupelli L, Dentamaro T, Lamanda M, Natale G, Palumbo R, Romani C, Tendas A, Tolu B, Violo L, de Fabritiis P. Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives. Cardiovascular & Hematological Agents in Medicinal Chemistry. 7: 305-12. PMID 19607642 DOI: 10.2174/187152509789541873 |
0.107 |
|
| 2012 |
Vischini G, Niscola P, Ferrannini M, Cupelli L, Tendas A, Scaramucci L, Giovannini M, Dentamaro T, de Fabritiis P, Palumbo R. [Membranous glomerulonephritis secondary to allogeneic stem cell transplant: review of the literature]. Giornale Italiano Di Nefrologia : Organo Ufficiale Della Società Italiana Di Nefrologia. 29: 394-403. PMID 22843152 |
0.098 |
|
| 2008 |
Scaramucci L, Niscola P, Ales M, Giovannini M, Tendas A, Cupelli L, Siniscalchi A, Piccioni D, Dentamaro T, Perrotti A, de Fabritiis P. Pure red cell aplasia associated with hemolytic anemia refractory to standard measures and resolved by rituximab in an elderly patient. International Journal of Hematology. 88: 343-344. PMID 18807120 DOI: 10.1007/s12185-008-0161-9 |
0.095 |
|
| 2013 |
Palombi M, Niscola P, Tendas A, Trawinska MM, Scaramucci L, Giovannini M, Fratoni S, Perrotti A, de Fabritiis P. Simultaneous occurrence of large B-cell non-Hodgkin lymphoma and acute myeloid leukaemia in an elderly patient: complete remissions of both diseases by rituximab-bendamustine regimen combined to hypomethylating therapy. Journal of Chemotherapy (Florence, Italy). 25: 247-9. PMID 23906078 DOI: 10.1179/1973947813Y.0000000076 |
0.091 |
|
| 2014 |
Tendas A, Cupelli L, Siniscalchi A, Scaramucci L, Giovannini M, Dentamaro T, Perrotti A, Caravita T, de Fabritiis P, Niscola P. Azacitidine in chronic myelomonocytic leukemia: an effective and manageable approach. Mediterranean Journal of Hematology and Infectious Diseases. 6: e2014020. PMID 24678397 DOI: 10.4084/MJHID.2014.020 |
0.09 |
|
| 2006 |
Niscola P, de Fabritiis P, Cartoni C, Romani C, Sorrentino F, Dentamaro T, Piccioni D, Scaramucci L, Giovannini M, Amadori S, Mandelli F. Home care management of patients affected by hematologic malignancies: a review. Haematologica. 91: 1523-9. PMID 17082010 |
0.089 |
|
| 2013 |
Niscola P, Tendas A, Giovannini M, Scaramucci L, Cupelli L, Catalano G, Perrotti A, de Fabritiis P. Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 1803-5. PMID 23604522 DOI: 10.1007/s00520-013-1818-3 |
0.089 |
|
| 2020 |
Heist R, Garon E, Tan D, Groen H, Seto T, Smit E, Nwana N, Fairchild L, Balbin A, Yan M, Wang I, Giovannini M, Sankaran B, Wolf J. B11 Accurate Detection of METex14 Mutations in Non-Small Cell Lung Cancer (NSCLC) with Comprehensive Genomic Sequencing: Results from the GEOMETRY Mono-1 Study Journal of Thoracic Oncology. 15: S30-S31. DOI: 10.1016/j.jtho.2019.12.080 |
0.089 |
|
| 2009 |
Cartoni C, Niscola P, Breccia M, Brunetti G, D'Elia GM, Giovannini M, Romani C, Scaramucci L, Tendas A, Cupelli L, de Fabritiis P, Foa R, Mandelli F. Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience. Leukemia & Lymphoma. 50: 387-91. PMID 19347728 DOI: 10.1080/10428190802714024 |
0.086 |
|
| 2013 |
Scaramucci L, Giovannini M, Niscola P, Perrotti A, de Fabritiis P. Primary mixed-type autoimmune hemolytic anemia concomitant with acute splanchnic venous thrombosis of idiopathic origin in a young woman: an unexplained association. Blood Research. 48: 292-3. PMID 24466555 DOI: 10.5045/br.2013.48.4.292 |
0.086 |
|
| 2015 |
Wolf J, Hochmair M, Kattan J, Ang M, Garon E, Groen H, Heist R, Ohashi K, Felip E, Reguart N, Garciac Campelo R, Soo R, Paz-Ares L, de Marinis F, Smit E, ... Giovannini M, et al. 478TiP A phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease Annals of Oncology. 26: ix125. DOI: 10.1093/annonc/mdv532.62 |
0.085 |
|
| 2012 |
Niscola P, Tendas A, Cupelli L, Catalano G, Scaramucci L, Giovannini M, Trinchieri V, Sharma A, Efficace F, Cartoni C, Piccioni D, Perrotti A, Dentamaro T, de Fabritiis P, Keefe DM. The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes. Cardiovascular & Hematological Agents in Medicinal Chemistry. 10: 362-75. PMID 22721442 DOI: 10.2174/187152512803530324 |
0.084 |
|
| 2009 |
Tendas A, Cupelli L, Dentamaro T, Scaramucci L, Palumbo R, Niscola P, Giovannini M, Piccioni D, Perrotti AP, de Fabritiis P. Feasibility of a dose-adjusted fludarabine-melphalan conditioning prior autologous stem cell transplantation in a dialysis-dependent patient with mantle cell lymphoma. Annals of Hematology. 88: 285-6. PMID 18690439 DOI: 10.1007/s00277-008-0578-5 |
0.08 |
|
| 2018 |
Abruzzese E, Trawinska MM, Neri B, Bondanini F, Fratoni S, Tendas A, Scaramucci L, Siniscalchi A, Giovannini M, Palumbo R, de Fabritiis P, Niscola P. Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm. Acta Haematologica. 140: 231-233. PMID 30384359 DOI: 10.1159/000493880 |
0.079 |
|
| 2009 |
Perrotti AP, Niscola P, Boemi S, Scaramucci L, Dentamaro T, Palombi M, Ales M, Cupelli L, Tendas A, Piccioni D, Giovannini M, Naso V, Martelli M, de Fabritiis P. Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy. Tumori. 95: 129-30. PMID 19366073 |
0.077 |
|
| 2015 |
Niscola P, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P, Howell DA. Caring for terminal patients in haematology: the urgent need of a new research agenda. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 5-7. PMID 25341550 DOI: 10.1007/s00520-014-2489-4 |
0.074 |
|
| 2009 |
Niscola P, Palumbo R, Scaramucci L, Tendas A, Cupelli L, Giovannini M, Piccioni D, Dentamaro T, Perrotti AP, de Fabritiis P. Successful treatment with a rituximab-based regimen of a splenic marginal zone lymphoma with villous lymphocytes in a very frail patient on maintenance dialysis. Cancer Chemotherapy and Pharmacology. 63: 759-60. PMID 18500519 DOI: 10.1007/s00280-008-0777-8 |
0.074 |
|
| 2013 |
Niscola P, Palombi M, Trawinska MM, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P. Managing myelodysplastic syndromes in very old patients: a teaching case report. Clinical Interventions in Aging. 8: 391-4. PMID 23610516 DOI: 10.2147/CIA.S39536 |
0.073 |
|
| 2010 |
Niscola P, Palombi M, Fratoni S, Trawinska MM, Scaramucci L, Giovannini M, Perrotti A, De Fabritiis P. Unusual sequence of lymphoid disorders: follicular lymphoma subsequent to Hodgkin lymphoma and transformed into diffuse large B-cells non Hodgkin lymphoma. Acta Oncologica (Stockholm, Sweden). 48: 1073-4. PMID 19308758 DOI: 10.1080/02841860902829213 |
0.073 |
|
| 2010 |
Ales M, Scaramucci L, Niscola P, Giovannini M, Palombi M, Tendas A, Cupelli L, Trawinska MM, Fratoni S, Perrotti A, de Fabritiis P. IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. Leukemia Research. 34: e58-9. PMID 19647315 DOI: 10.1016/j.leukres.2009.07.014 |
0.072 |
|
| 2009 |
Scaramucci L, Niscola P, Fratoni S, Giovannini M, Cupelli L, Tendas A, Ales M, Natale G, Perrotti AP, de Fabritiis P. Multicentric myeloid/NK sarcoma in an aleukemic patient evolved in refractory acute leukemia. Leukemia Research. 33: 1294-6. PMID 19329184 DOI: 10.1016/j.leukres.2009.01.037 |
0.07 |
|
| 2012 |
Scaramucci L, Giovannini M, Niscola P, Palombi M, Cupelli L, Tendas A, Perrotti AP, de Fabritiis P. IgA-induced autoimmune hemolytic anemia in a patient with antiphospholipid syndrome. Asian Journal of Transfusion Science. 6: 188. PMID 22988389 DOI: 10.4103/0973-6247.98950 |
0.068 |
|
| 2017 |
Niscola P, Abruzzese E, Trawinska MM, Palombi M, Tendas A, Giovannini M, Scaramucci L, Cupelli L, Fratoni S, Noguera NI, Catalano G, de Fabritiis P. Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. Acta Oncologica (Stockholm, Sweden). 1-2. PMID 28488914 DOI: 10.1080/0284186X.2017.1324215 |
0.068 |
|
| 2011 |
Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program. Indian Journal of Palliative Care. 17: 54-6. PMID 21633622 DOI: 10.4103/0973-1075.78450 |
0.068 |
|
| 2007 |
Niscola P, Perrotti AP, del Poeta G, Romani C, Palombi M, Piccioni D, Scaramucci L, Tolu B, Tendas A, Cupelli L, Abruzzese E, D'Elia GM, Brunetti GA, Maurillo L, Giovannini M, et al. Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures. Herpes : the Journal of the Ihmf. 14: 45-7. PMID 17939903 |
0.068 |
|
| 2004 |
Gaudio C, Ferri FM, Giovannini M, Pannarale G, Puddu PE, Vittore A, Fera MS, Vizza CD, Fedele F. Comparative effects of irbesartan versus amlodipine on left ventricular mass index in hypertensive patients with left ventricular hypertrophy. Journal of Cardiovascular Pharmacology. 42: 622-8. PMID 14576510 DOI: 10.1097/00005344-200311000-00007 |
0.066 |
|
| 2013 |
Niscola P, Tendas A, Scaramucci L, Giovannini M, Cupelli L, Fratoni S, Perrotti A, de Fabritiis P. Gingival myeloid sarcoma in myelodysplastic syndrome. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 917-8. PMID 23288397 DOI: 10.1007/s00520-012-1702-6 |
0.065 |
|
| 2013 |
Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P. Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome. Blood Research. 48: 152-3. PMID 23826588 DOI: 10.5045/br.2013.48.2.152 |
0.065 |
|
| 2009 |
Siniscalchi A, Tendas A, Ales M, Fratoni S, Cupelli L, Dentamaro T, Scaramucci L, Giovannini M, Caravita T, Santeusanio G, Niscola P, de Fabritiis P. Bortezomib-related colon mucositis in a multiple myeloma patient. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 17: 325-7. PMID 19172306 DOI: 10.1007/s00520-008-0573-3 |
0.065 |
|
| 2019 |
Niscola P, Noguera NI, Catalano G, Cupelli L, Fratoni S, Giovannini M, Mazzone C, Neri B, Scaramucci L, Trawinska MM, de Fabritiis P, Abruzzese E. Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy. Acta Oncologica (Stockholm, Sweden). 1-3. PMID 30848978 DOI: 10.1080/0284186X.2019.1585943 |
0.064 |
|
| 2011 |
Niscola P, Vischini G, Tendas A, Scaramucci L, Giovannini M, Bondanini F, Romani C, Brunetti GA, Cartoni C, Cupelli L, Ferrannini M, Perrotti A, Del Poeta G, Palumbo R, de Fabritiis P. Management of hematological malignancies in patients affected by renal failure. Expert Review of Anticancer Therapy. 11: 415-32. PMID 21417855 DOI: 10.1586/era.11.2 |
0.064 |
|
| 2013 |
Niscola P, Tendas A, Luo XD, Catalano G, Scaramucci L, Cupelli L, Giovannini M, Ferranini M, Bondanini F, Piccioni D, Dentamaro T, Palumbo R, Perrotti AP, Liu QF, de Fabritiis P. The management of membranous glomerulopathy in allogeneic stem cells transplantation: updated literature. Cardiovascular & Hematological Agents in Medicinal Chemistry. 11: 67-76. PMID 23016546 DOI: 10.2174/1871525711311010011 |
0.064 |
|
| 2011 |
Brunetti GA, Tendas A, Meloni E, Mancini D, Maggiore P, Scaramucci L, Giovannini M, Niscola P, Cartoni C, Alimena G. Pain and anxiety associated with bone marrow aspiration and biopsy: a prospective study on 152 Italian patients with hematological malignancies. Annals of Hematology. 90: 1233-5. PMID 21287348 DOI: 10.1007/s00277-011-1166-7 |
0.062 |
|
| 2017 |
Niscola P, Tendas A, Abruzzese E, Caravita T, Cupelli L, Giovannini M, Scaramucci L, Siniscalchi A, Trawinska MM, de Fabritiis P. Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice. Annals of Hematology. 96: 1591-1593. PMID 28702776 DOI: 10.1007/s00277-017-3064-0 |
0.062 |
|
| 2015 |
Niscola P, Tendas A, Scaramucci L, Giovannini M, Fratoni S, de Fabritiis P. Successful re-treatment with azacitidine in a patient with low blast count AML transformed from MDS after suspension of this agent. Blood Research. 50: 113-4. PMID 26157782 DOI: 10.5045/br.2015.50.2.113 |
0.062 |
|
| 2013 |
Niscola P, Tendas A, Cupelli L, Neri B, Scaramucci L, Morino L, Giovannini M, Fratoni S, de Fabritiis P. Necrotizing fasciitis in myelodysplastic syndrome: an exceptionally rare occurrence. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 21: 365-6. PMID 22960853 DOI: 10.1007/s00520-012-1588-3 |
0.062 |
|
| 2009 |
Niscola P, Palombi M, Trawinska MM, Scaramucci L, Giovannini M, Perrotti AP, Fabritiis Pd, Fratoni S. Primary anaplastic large B-cell lymphoma in mandible: Long-term complete remission with R-CHOP regimen and involved field radiotherapy. Oral Oncology. 45: e113. PMID 19457710 DOI: 10.1016/j.oraloncology.2009.04.002 |
0.06 |
|
| 2004 |
Niscola P, Arcuri E, Giovannini M, Scaramucci L, Romani C, Palombi F, Trapè G, Morabito F. Pain syndromes in haematological malignancies: an overview. The Hematology Journal : the Official Journal of the European Haematology Association / Eha. 5: 293-303. PMID 15297845 DOI: 10.1038/sj.thj.6200530 |
0.06 |
|
| 2010 |
Niscola P, Scaramucci L, Romani C, Giovannini M, Tendas A, Brunetti G, Cartoni C, Palumbo R, Vischini G, Siniscalchi A, de Fabritiis P, Caravita T. Pain management in multiple myeloma. Expert Review of Anticancer Therapy. 10: 415-25. PMID 20214522 DOI: 10.1586/era.10.5 |
0.06 |
|
| 2012 |
Niscola P, Tendas A, Giovannini M, Cupelli L, Trawinska MM, Palombi M, Scaramucci L, Brunetti GA, Perrotti A, Neri B, Efficace F, Cartoni C, de Fabritiis P, Mandelli F. Transfusions at home in patients with myelodysplastic syndromes. Leukemia Research. 36: 684-8. PMID 22336393 DOI: 10.1016/j.leukres.2012.01.010 |
0.059 |
|
| 2010 |
Tendas A, Niscola P, Cinque R, Cupelli L, Giovannini M, Ales M, Dentamaro T, Scaramucci L, de Fabritiis P. Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. Leukemia Research. 34: e66. PMID 19717190 DOI: 10.1016/j.leukres.2009.08.002 |
0.057 |
|
| 2011 |
Tendas A, Niscola P, Barbati R, Abruzzese E, Cuppelli L, Giovannini M, Scaramucci L, Fratoni S, Ales M, Neri B, Morino L, Dentamaro T, De Fabritiis P. Tattoo related pyoderma/ectyma gangrenous as presenting feature of relapsed acute myeloid leukaemia: an exceptionally rare observation. Injury. 42: 546-7. PMID 20883993 DOI: 10.1016/j.injury.2010.08.014 |
0.055 |
|
| 2010 |
Tendas A, Niscola P, Fratoni S, Cupelli L, Morino L, Neri B, Ales M, Scaramucci L, Giovannini M, Barbati R, Dentamaro T, de Fabritiis P. Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 18: 1495-7. PMID 20882392 DOI: 10.1007/s00520-010-1012-9 |
0.053 |
|
| 2014 |
Niscola P, Ragusa D, Scaramucci L, Giovannini M, Piccioni D, Tendas A, Perrotti A, de Fabritiis P, Del Poeta G. Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. Annals of Hematology. 93: 863-5. PMID 23949377 DOI: 10.1007/s00277-013-1877-z |
0.053 |
|
| 2016 |
Niscola P, Tendas A, Giovannini M, Costa A, Venditti D, Volta L, Malandruccolo L, Sabbadini S, Lasorella R, Fabritiis P, Cassetta R, Perrotti AP. At-home application of autologous platelet rich plasma as treatment for pressure sore and related anemia. Cardiovascular & Hematological Agents in Medicinal Chemistry. PMID 27292011 |
0.053 |
|
| 2013 |
Niscola P, Catalano G, Tendas A, Giovannini M, Scaramucci L, Neri B, Morino L, Piccioni D, Fratoni S, Perrotti A, de Fabritiis P. Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy. Mediterranean Journal of Hematology and Infectious Diseases. 5: e2013030. PMID 23667728 DOI: 10.4084/MJHID.2013.030 |
0.053 |
|
| 2009 |
Tendas A, Niscola P, Ales M, Baraldi L, Boschetto C, Caiazza E, Cupelli L, Giovannini M, Scaramucci L, Brunetti G, Cartoni C, Mandelli F, de Fabritiis P. Disability and physical rehabilitation in patients with advanced hematological malignancies followed in a home care program. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 17: 1559-60. PMID 19701814 DOI: 10.1007/s00520-009-0732-1 |
0.053 |
|
| 2016 |
Palombi M, Scaramucci L, Giovannini M, Trawinska MM, Niscola P, de Fabritiis P. Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab? Blood Research. 51: 66. PMID 27104196 DOI: 10.5045/br.2016.51.1.66 |
0.05 |
|
| 2014 |
Niscola P, Tendas A, Scaramucci L, Giovannini M, Piccioni D, de Fabritiis P. Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy. Blood Research. 49: 65-6. PMID 24724070 DOI: 10.5045/br.2014.49.1.65 |
0.049 |
|
| 2010 |
Tendas A, Niscola P, Cupelli L, Giovannini M, Scaramucci L, Ales M, Morino L, Dentamaro T, de Fabritiis P. Sleep complaints in hospitalized Italian patients with hematological malignancies. Internal Medicine (Tokyo, Japan). 49: 1689; author reply 1. PMID 20686322 DOI: JST.JSTAGE/internalmedicine/49.3747 |
0.047 |
|
| 2011 |
Tendas A, Niscola P, Giovannini M, Scaramucci L, Cupelli L, Dentamaro T, de Fabritiis P. Epidemiology and pathogenesis of incident pain-related disability in malignant hematology: an Italian survey. Annals of Hematology. 90: 719-20. PMID 20827476 DOI: 10.1007/s00277-010-1064-4 |
0.045 |
|
| 2018 |
Giovannini M, Cao J, Ehmann K. Design and models of helical needle geometries for core biopsies. Journal of the Mechanical Behavior of Biomedical Materials. 90: 113-124. PMID 30366301 DOI: 10.1016/J.Jmbbm.2018.09.036 |
0.044 |
|
| 2009 |
Niscola P, Tendas A, Scaramucci L, Fratoni S, Giovannini M, Ales M, Cupelli L, Natale G, Dentamaro T, De Fabritiis P. Isolated bone involvement of a single lumbar vertebra body as unusual presentation of relapsing Hodgkin's lymphoma. Acta Oncologica (Stockholm, Sweden). 48: 1085-6. PMID 19449222 DOI: 10.1080/02841860902968060 |
0.043 |
|
| 2011 |
Niscola P, Giovannini M, Scaramucci L, Palombi M, Tendas A, Cupelli L, Perrotti AP, de Fabritiis P. Idiopathic thrombocytopenic purpura coexisting with polycythemia vera. Asian Journal of Transfusion Science. 5: 187-8. PMID 21897612 DOI: 10.4103/0973-6247.83265 |
0.043 |
|
| 2006 |
Niscola P, Scaramucci L, Romani C, Giovannini M, Maurillo L, del Poeta G, Cartoni C, Arcuri E, Amadori S, De Fabritiis P. Opioids in pain management of blood-related malignancies. Annals of Hematology. 85: 489-501. PMID 16572325 DOI: 10.1007/s00277-005-0062-4 |
0.042 |
|
| 2015 |
Niscola P, Tendas A, Cupelli L, Giovannini M, Piccioni D, Scaramucci L, Dentamaro T, Del Poeta G, de Fabritiis P. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting. Acta Haematologica. 133: 64-6. PMID 25139255 DOI: 10.1159/000363643 |
0.042 |
|
| 2014 |
Scaramucci L, Giovannini M, Niscola P, Tendas A, Perrotti A, De Fabritiis P. Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura. Blood Transfusion = Trasfusione Del Sangue. 12: 605-7. PMID 25351191 DOI: 10.2450/2014.0246.13 |
0.04 |
|
| 2014 |
Scaramucci L, Giovannini M, Niscola P, Tendas A, Perrotti A, De Fabritiis P. Reciprocal absence of cross-resistance between eltrombopag and romiplostim in two patients with refractory immune thrombocytopenic purpura. Blood Transfusion = Trasfusione Del Sangue. 1-3. PMID 24887225 DOI: 10.2450/2014.0246-13 |
0.04 |
|
| 2011 |
Niscola P, Giovannini M, Vischini G, Scaramucci L, Ferrannini M, Tendas A, Cupelli L, Bondanini F, Di Daniele N, Palumbo R. [Opioid analgesics in patients with chronic renal failure: principles for use and current guidelines]. Giornale Italiano Di Nefrologia : Organo Ufficiale Della Società Italiana Di Nefrologia. 28: 269-77. PMID 21626495 |
0.04 |
|
| 2014 |
Niscola P, Giovannini M, Tendas A, Scaramucci L, Perrotti A, De Fabritiis P. Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome. Blood Transfusion = Trasfusione Del Sangue. 12: s160-1. PMID 23522884 DOI: 10.2450/2013.0232-12 |
0.039 |
|
| 2010 |
Niscola P, Palmieri MB, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Palumbo R, Fratoni S. Fulminant thrombotic microangiopathy as a clinical presentation of an occult signet-ring cell carcinoma of the lung and misdiagnosed as idiopathic thrombotic thrombocytopenic purpura. Saudi Medical Journal. 31: 581. PMID 20464054 |
0.039 |
|
| 2009 |
Palombi M, Niscola P, Trawinska MM, Scaramucci L, Giovannini M, Perrotti A, de Fabritiis P. Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins. Blood Transfusion = Trasfusione Del Sangue. 7: 235-6. PMID 19657487 DOI: 10.2450/2008.0066-08 |
0.039 |
|
| 2011 |
Vischini G, Niscola P, Tendas A, Cupelli L, Giovannini M, Ferrannini M, Brunetti GA, Cartoni C, de Fabritiis P, Palumbo R. Management of Peritoneal Dialysis within a Home Care Program for Hematological Malignancies: Concerns and Perspectives Illustrated by a Case Report. Indian Journal of Palliative Care. 17: 166-7. PMID 21976861 DOI: 10.4103/0973-1075.84542 |
0.038 |
|
| 2002 |
Gaudio C, Vittore A, Mirabelli F, Nguyen BL, Giovannini M, Mazza A, Iaia L, Alessandri N. Magnetic resonance coronary angiography: present clinical applications. Italian Heart Journal : Official Journal of the Italian Federation of Cardiology. 3: 497-505. PMID 12407845 |
0.038 |
|
| 2012 |
Niscola P, Scaramucci L, Giovannini M, Tendas A, Cupelli L, Perroti AP, de Fabritiis P. Fever of unknown origin, anemia and thrombocytosis as early symptoms and signs of a late-onset polymialgia rheumatica: a diagnostic challenge. Annals of Saudi Medicine. 32: 322-3. PMID 22588450 DOI: 10.5144/0256-4947.2012.322 |
0.038 |
|
| 2012 |
Niscola P, Palombi M, Fratoni S, Trawinska MM, Scaramucci L, Tendas A, Giovannini M, Perrotti A, de Fabritiis P. Long-term survival of a patient with bone marrow gelatinous degeneration of idiopathic origin. The Korean Journal of Hematology. 47: 309-10. PMID 23320013 DOI: 10.5045/kjh.2012.47.4.309 |
0.037 |
|
| 2010 |
Niscola P, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Massa P, Tatangelo P, Galletti M, Palumbo R. The use of major analgesics in patients with renal dysfunction. Current Drug Targets. 11: 752-8. PMID 20041843 DOI: 10.2174/138945010791170879 |
0.035 |
|
| 2011 |
Tendas A, Niscola P, Cupelli L, Spagnoli A, Scaramucci L, Giovannini M, Ales M, Cudillo L, Picardi A, Mirabile M, Bove F, Falco S, Dentamaro T, Fabritiis Pd. Controversies on antibiotic lock technique duration: experience with a 3-day course for hematological patients. Infection Control and Hospital Epidemiology. 32: 408-10. PMID 21460500 DOI: 10.1086/659257 |
0.034 |
|
| 2018 |
Giovannini M, Ren H, Cao J, Ehmann K. Study on design and cutting parameters of rotating needles for core biopsy. Journal of the Mechanical Behavior of Biomedical Materials. 86: 43-54. PMID 29933201 DOI: 10.1016/J.Jmbbm.2018.06.013 |
0.034 |
|
| 2015 |
Tendas A, Lissia MF, Piccioni D, Tirimbelli L, Scaramucci L, Giovannini M, Dentamaro T, Perrotti A, de Fabritiis P, Niscola P. Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 23: 303-5. PMID 25370894 DOI: 10.1007/s00520-014-2502-y |
0.034 |
|
| 2017 |
Niscola P, Neri B, Catalano G, Morino L, Giovannini M, Scaramucci L, Fratoni S, Noguera NI, Cordone I, de Fabritiis P. Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. Acta Oncologica (Stockholm, Sweden). 56: 1120-1121. PMID 28406054 DOI: 10.1080/0284186X.2017.1287947 |
0.033 |
|
| 2004 |
Begue B, Dumant C, Bambou J, Beaulieu J, Giovannini M, Cerf-Bensussan N, Philpott D, Ruemmele FM. O0105 CROHN???S DISEASE AS AN INNATE IMMUNE DEFECT ???THE CRITICAL ROLE OF CARD15 IN INTESTINAL ANTIBACTERIAL DEFENSE Journal of Pediatric Gastroenterology and Nutrition. 39: S48. DOI: 10.1097/00005176-200406001-00107 |
0.033 |
|
| 2014 |
Tendas A, Niscola P, Scaramucci L, Giovannini M, Dentamaro T, Perrotti AP, de Fabritiis P. Motor disability, clinical complications, quality of life, and survival in patients with cancer: a plausible scenario. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 2603-4. PMID 24659217 DOI: 10.1007/s00520-014-2213-4 |
0.031 |
|
| 2010 |
Tendas A, Niscola P, Dentamaro T, Cupelli L, Di Matteo G, Finocchi A, Siniscalchi A, Fratoni S, Scimò T, Scaramucci L, Giovannini M, Ales M, Pio Perrotti A, de Fabritiis P. Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). Annals of Hematology. 89: 949-51. PMID 20077117 DOI: 10.1007/s00277-009-0891-7 |
0.03 |
|
| 2012 |
Niscola P, Tendas A, Giovannini M, Scaramucci L, Cupelli L, Ferrannini M, Brunetti GA, Bondanini F, Palumbo R, Perrotti A, Romani C, Cartoni C, Efficace F, de Fabritiis P. Pain management in hematological patients with major organ dysfunctions and comorbid illnesses. Cardiovascular & Hematological Agents in Medicinal Chemistry. 10: 135-47. PMID 22352683 |
0.028 |
|
| 2008 |
Tendas A, Niscola P, Cupelli L, Dentamaro T, Scaramucci L, Siniscalchi A, Ales M, Giovannini M, Perrotti A, de Fabritiis P. Palliative sedation therapy in a bone marrow transplant unit. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 17: 107-8. PMID 18982361 DOI: 10.1007/s00520-008-0525-y |
0.028 |
|
| 2022 |
Webster S, Giovannini M, Shi Y, Martinez-Prieto N, Fezzaa K, Sun T, Ehmann K, Cao J. High-throughput, in situ imaging of multi-layer powder-blown directed energy deposition with angled nozzle. The Review of Scientific Instruments. 93: 023701. PMID 35232143 DOI: 10.1063/5.0077140 |
0.028 |
|
| 2014 |
Tendas A, Niscola P, Scaramucci L, Giovannini M, Dentamaro T, Perrotti AP, de Fabritiis P. Making quality of life assessment a dashboard for patient management. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 2311-2. PMID 24993396 DOI: 10.1007/s00520-014-2342-9 |
0.026 |
|
| 2008 |
Niscola P, Piccioni D, Scaramucci L, Fratoni S, Tendas A, Cupelli L, Dentamaro T, Giovannini M, Pio Perrotti A, Del Poeta G, de Fabritiis P. Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera. International Journal of Hematology. 86: 377-8. PMID 18055349 DOI: 10.1532/IJH97.E0726 |
0.02 |
|
| 2013 |
Scaramucci L, Giovannini M, Tendas A, Niscola P, de Fabritiis P. Late but effective long-term response to splenectomy in the treatment of immune thrombocytopenia. Blood Research. 48: 297-8. PMID 24466558 DOI: 10.5045/br.2013.48.4.297 |
0.017 |
|
| 2011 |
Vischini G, Tendas A, Ferrannini M, Scaramucci L, Di Segni G, Giovannini M, Niscola P, Palumbo R. Motor disability in end-stage renal failure: an epidemiological study on Italian dialyzed patients. Saudi Journal of Kidney Diseases and Transplantation : An Official Publication of the Saudi Center For Organ Transplantation, Saudi Arabia. 22: 1236-7. PMID 22089791 |
0.014 |
|
| 2012 |
Tendas A, Niscola P, Cupelli L, Scaramucci L, Giovannini M, de Fabritiis P. Single versus double-unit transfusion policy in hematology. Haematologica. 97: e25. PMID 22798546 DOI: 10.3324/haematol.2012.065516 |
0.014 |
|
| 2011 |
Scaramucci L, Tendas A, Niscola P, Bondanini F, Giovannini M, Palombi M, Cupelli L, Efficace F, Perrotti A, de Fabritiis P. Motor disability in the setting of oral anticoagulant therapy. International Journal of Hematology. 94: 499-500. PMID 22038014 DOI: 10.1007/s12185-011-0945-1 |
0.013 |
|
| 2009 |
Scaramucci L, Niscola P, Palumbo R, Giovannini M, Ales M, Tendas A, Cupelli L, Natale G, Dentamaro T, Perrotti AP, de Fabritiis P. Rapid response and sustained remission by rituximab in four cases of plasma-exchange-failed acute thrombotic thrombocytopenic purpura. International Journal of Hematology. 89: 398-9. PMID 19294484 DOI: 10.1007/s12185-009-0274-9 |
0.012 |
|
| 2011 |
Tendas A, Cupelli L, Scaramucci L, Palombi M, Trawinska MM, Giovannini M, Brunetti GA, Cartoni C, Bondanini F, de Fabritiis P, Niscola P. Authors' reply. Indian Journal of Palliative Care. 17: 260-1. PMID 22346057 |
0.01 |
|
| 2008 |
Niscola P, Romani C, Cartoni C, Cupelli L, Piccioni D, Dentamaro T, Tendas A, Giovannini M, Scaramucci L, Tolu B, Perrotti AP, de Fabritiis P. Epidemiology of pain in hospital haematological setting: an Italian survey. Leukemia Research. 32: 197-8. PMID 17466372 DOI: 10.1016/j.leukres.2007.03.024 |
0.01 |
|
| Hide low-probability matches. |
